Smart Discharges for Older Children

ConditionSepsis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age5-16
SponsorUniversity of British Columbia

About this trial

This study is an observational multi-country cohort study that aims to build algorithms that can identify children between 5 and 16 years of age admitted for proven or suspected sepsis who are at risk of mortality after they are discharged in East Africa.

In low- and middle-income countries, about 5% of children discharged after hospitalization for sepsis will die in the weeks after returning home. Doctors and parents are often unaware of this period of vulnerability and are poorly equipped to identify or handle this critical situation. This project builds on past work that developed and evaluated models and the Smart Discharges program to predict, during hospitalization, an individual child's risk of recurrent illness and mortality, as well as to provide additional post-discharge support to at-risk children.

Participants will be enrolled from facilities once they are admitted, collecting clinical and social variables. They will then be followed until 6 months post-discharge to understand what happens to them after they return home. This data will be evaluated to identify which variables collected at facilities can be predictive of mortality and recurrent illness after discharge.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age between 0 and 16 years admitted to pediatric ward of hospital for proven or suspected infection

Provide informed consent

Ability to provide contact information (phone number or address) for phone or in-person follow-up

Disqualifiers

Child lives outside of the catchment area of a study site

Admitted for elective procedures, trauma, or short-term observation

Language barriers

Trial population

The study population is children admitted to hospital facilities with suspected or proven sepsis between 5-16 years of age in the catchment area of the 8 study sites: Mbarara Regional Referral Hospital (Uganda), Jinja Regional Referral Hospital (Uganda), Uganda Martyrs Ibanda Hospital (Uganda), Holy Innocents Children's Hospital (Uganda), Sekou-Toure Regional Referral Hospital (Tanzania), Bugando Medical Centre (Tanzania), Masaka Hospital (Rwanda), University Teaching Hospital of Kigali (Rwanda), Ruhengeri Referral Hospital (Rwanda).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • No Intervention: Observational Cohort

    Other intervention

    This is a non-interventional study

Treatment groups

4,000 Participants
are divided into 1 treatment group
Group A: Pediatric patients 5-16 years of age1 intervention

Trial outcomes

Primary outcomes

1

Number of children who die post-discharge

Time frame
Discharge until 6 months post-discharge

Secondary outcomes

1

Number of children readmitted to a health facility post-discharge

Time frame
Discharge until 6 months post-discharge

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of British Columbia

Lead sponsor

University of California, San Francisco

Collaborator

World Alliance for Lung and Intensive Care Medicine in Uganda

Collaborator

Catholic University of Health and Allied Sciences

Collaborator

Centre Hospitalier Universitaire de Kigali

Collaborator